Maha Abdelrahman
- Hematology top 10%
- Erythropoietin and Anemia Treatment 2
- Nephrology top 10%
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology 3
-
- Cardiac Ischemia and Reperfusion 2
-
- Peroxisome Proliferator-Activated Receptors 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Systemic Lupus Erythematosus Research 2
-
- Calpain Protease Function and Regulation 1
-
- Nitric Oxide and Endothelin Effects 1
- Co-authors
- Christoph ThiemermannAhila SivarajahMichelle C. McDonaldMuhammad YaqoobMarika CollinSalvatore CuzzocreaHélder Mota‐FilipeEdward Sharples
- Cited by
- HematologyNephrologyBiochemistry
- Journals
- SHILAP Revista de lepidopterología (2 papers)The FASEB Journal (1 paper)British Journal of Pharmacology (2 papers)
- Partner nations
- United KingdomItalyEgypt
In The Last Decade
Maha Abdelrahman
12 papers receiving 595 citations
Peers
Comparison fields: 5 of 82
- Hematology 108
- Nephrology 68
- Biochemistry 58
- Transplantation 15
- Pathology and Forensic Medicine 76
Countries citing papers authored by Maha Abdelrahman
This map shows the geographic impact of Maha Abdelrahman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Abdelrahman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Abdelrahman more than expected).
Fields of papers citing papers by Maha Abdelrahman
This network shows the impact of papers produced by Maha Abdelrahman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Abdelrahman. The network helps show where Maha Abdelrahman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maha Abdelrahman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2020 | 1 | |
| 4 | 2007 | 17 | |
| 5 | 2006 | 48 | |
| 6 | 2006 | 12 | |
| 7 | 2005 | 180 | |
| 8 | 2004 | 26 | |
| 9 | 2004 | 130 | |
| 10 | 2003 | 17 | |
| 11 | 2003 | 1 | |
| 12 | 2001 | 91 | |
| 13 | 2000 | 78 |
About Maha Abdelrahman
Maha Abdelrahman is a scholar working on Biochemistry, Transplantation and Hematology, having authored 13 papers that have together received 606 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (3 papers), Erythropoietin and Anemia Treatment (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Cardiac Ischemia and Reperfusion (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Systemic Lupus Erythematosus Research (2 papers), Calpain Protease Function and Regulation (1 paper) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Hematology (108 citations), Nephrology (68 citations) and Biochemistry (58 citations). Maha Abdelrahman has collaborated with scholars based in United Kingdom, Italy and Egypt. Frequent co-authors include Christoph Thiemermann, Ahila Sivarajah, Michelle C. McDonald, Muhammad Yaqoob, Marika Collin, Salvatore Cuzzocrea, Hélder Mota‐Filipe, Edward Sharples, Nimesh S. A. Patel and Michael D. Threadgill. Their work appears in journals such as SHILAP Revista de lepidopterología, The FASEB Journal and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.